- Report
- July 2023
- 145 Pages
Global
From €2773EUR$3,150USD£2,397GBP
- Report
- May 2025
- 114 Pages
Global
From €4182EUR$4,750USD£3,614GBP
- Report
- May 2025
- 120 Pages
Global
From €4182EUR$4,750USD£3,614GBP
- Report
- April 2023
- 105 Pages
Global
From €4182EUR$4,750USD£3,614GBP
- Drug Pipelines
- April 2025
- 400 Pages
Global
From €4402EUR$5,000USD£3,804GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1761EUR$2,000USD£1,522GBP
- Report
- January 2024
- 120 Pages
Global
From €6999EUR$7,950USD£6,049GBP
- Report
- April 2023
- 399 Pages
Global
From €8363EUR$9,500USD£7,228GBP
- Report
- May 2023
- 120 Pages
Global
From €3962EUR$4,500USD£3,424GBP
- Report
- July 2024
- 171 Pages
Global
From €3962EUR$4,500USD£3,424GBP
- Report
- September 2023
- 115 Pages
Global
From €3962EUR$4,500USD£3,424GBP
- Report
- July 2024
- 200 Pages
Global
From €4357EUR$4,949USD£3,766GBP
- Report
- June 2024
- 140 Pages
Europe
From €3406EUR$3,869USD£2,944GBP
- Report
- August 2024
- 200 Pages
Global
From €4357EUR$4,949USD£3,766GBP
- Report
- April 2023
- 147 Pages
Global
From €4357EUR$4,949USD£3,766GBP
- Report
- December 2023
- 150 Pages
Global
From €3918EUR$4,450USD£3,386GBP
- Report
- March 2023
- 211 Pages
Global
From €3918EUR$4,450USD£3,386GBP
- Report
- July 2024
- 108 Pages
Middle East, Africa
From €3037EUR$3,450USD£2,625GBP
- Report
- January 2024
- 95 Pages
Middle East, Africa
From €3037EUR$3,450USD£2,625GBP
From €3037EUR$3,450USD£2,625GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more